Product logins

Find logins to all Clarivate products below.


Blog: Biopharma

Here you will find relevant articles and insight into all Clarivate related products and news.

The competitive signals hiding in plain sight for biopharma The competitive signals hiding in plain sight for biopharma
Blog May 8, 2026
The competitive signals hiding in plain sight for biopharma
Biopharma Business Development Clinical trials
Five lessons learned deploying agentic AI in the life sciences Five lessons learned deploying agentic AI in the life sciences
Blog April 30, 2026
Five lessons learned deploying agentic AI in the life sciences
AI
Target selection and safety assessment: Navigating early decisions that shape drug development Target selection and safety assessment: Navigating early decisions that shape drug development
Blog March 27, 2026
Target selection and safety assessment: Navigating early decisions that shape drug development
Development Pharma Regulatory
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
Blog March 26, 2026
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
GLP-1 Metabolic
Why longevity might be biopharma's next big thing: The science and business converge Why longevity might be biopharma's next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma's next big thing: The science and business converge
Gerontology
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Biotech Clinical trials
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar
FDA Regulatory Safety

Biopharma

Blog December 12, 2019
Express Scripts a Pioneer: Launches Curated List of Digital Therapeutics
Blog December 9, 2019
ASH 2019: How Can CAR T-cell Developers Ensure Differentiation in NHL?
Blog November 29, 2019
India: The emerging hub for biologics and biosimilars
Blog November 20, 2019
Massachusetts Law Allowing Coupons Expires on Jan 1, 2020 Unless State Acts
Expected blockbusters: A year in progress Expected blockbusters: A year in progress
Blog November 18, 2019
Expected blockbusters: A year in progress
Blog November 18, 2019
Digital Therapeutics Target Mental Health, Substance Use Disorders
Blog November 15, 2019
Never Mind Novartis’ DTxit -- Digital Therapeutics is Still the Future
Blog October 30, 2019
Cell and Gene Therapies: Five Key Access and Reimbursement Strategies
Tenofovir alafenamide fumarate raises targeting questions Tenofovir alafenamide fumarate raises targeting questions
Blog October 17, 2019
Tenofovir alafenamide fumarate raises targeting questions
Uncovering the potential cause of rare diseases Uncovering the potential cause of rare diseases
Blog October 16, 2019
Uncovering the potential cause of rare diseases